Form D · Biotechnology
ALTAIR THERAPEUTICS, INC.
San Diego, CA · CIK 0001476989
Offering snapshot reported Nov 17, 2009 · SEC filing
- Reported sold
- $6.47M Offering amount: $6.47M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $90K Reported outside-investor minimum
- First sale
- Nov 4, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 17, 2009 | Initial | $6,466,666 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-136204
Source: Form D, filed Nov 17, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Brown | Director |
| Nicole Deberg | Executive |
| Kim Kamdar | Director |
| Joel Martin | Director, Executive |
| Ivor Royston | Director |
| Pratik Shah | Director |
| David Shapiro | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12555 High Bluff Drive Suite 310
San Diego, CA, 92130
San Diego, CA, 92130